Vicarious Surgical Inc. Class A Common Stock (RBOT)
Frequently Asked Questions About Vicarious Surgical Inc. Class A Common Stock (RBOT)
How can interested parties keep updated on Vicarious Surgical?
Interested parties can stay updated on Vicarious Surgical by following their official website, subscribing to newsletters, and checking investor relations announcements. Additionally, social media platforms and financial news outlets often cover developments related to the company.
How can investors acquire shares of Vicarious Surgical?
Investors can acquire shares of Vicarious Surgical by purchasing them through a brokerage firm that allows trading on the New York Stock Exchange (NYSE) using the ticker symbol 'RBOT.' It’s advisable for investors to conduct proper research before buying shares to understand the associated risks.
How does Vicarious Surgical ensure safety and effectiveness in its devices?
Vicarious Surgical ensures safety and effectiveness by conducting rigorous preclinical and clinical testing, adhering to regulatory standards, and seeking feedback from surgeons during the development process. This allows them to refine their technology before it reaches the market.
How is Vicarious Surgical funded?
Vicarious Surgical has raised capital through several funding rounds, including its initial public offering (IPO), private investments, and collaborations with strategic partners. This funding supports their research, development, and commercialization efforts.
In what stage is Vicarious Surgical's product development?
As of now, Vicarious Surgical is in the advanced stages of product development and has been conducting clinical trials to test its robotic surgical systems. The company aims to bring its technology to market after comprehensive validation of its safety and efficacy.
What are the challenges facing Vicarious Surgical?
Some challenges facing Vicarious Surgical include navigating complex regulatory approval processes, competing with established companies in the robotic surgical space, and achieving widespread adoption of its technology within surgical communities. The company must continuously innovate to stay ahead.
What are the potential benefits of Vicarious Surgical's technology?
The potential benefits of Vicarious Surgical's technology include reduced recovery times, less pain for patients, and improved surgical precision leading to better outcomes. The use of robotics in surgery may also decrease hospital stays and minimize complications.
What does the 'RBOT' ticker symbol represent?
The ticker symbol 'RBOT' represents Vicarious Surgical Inc.'s Class A Common Stock on the New York Stock Exchange (NYSE). Investors can use this symbol to track the company's stock performance and engage in trading activities.
What does Vicarious Surgical Inc. do?
Vicarious Surgical Inc. develops innovative robotic surgical systems aimed at enhancing minimally invasive surgical procedures. The company focuses on creating a novel surgical platform that combines advanced robotics, artificial intelligence, and real-time imaging to improve surgical precision and patient outcomes.
What is the focus of Vicarious Surgical's technology?
The focus of Vicarious Surgical's technology is to create a robotic surgical system that allows surgeons to perform procedures with enhanced dexterity and visualization. Their platform seeks to optimize minimally invasive techniques that lead to quicker recovery times and less trauma for patients.
What is unique about Vicarious Surgical's approach to robotics?
Vicarious Surgical's approach is unique due to its combination of advanced robotics, augmented reality, and real-time data access, which gives surgeons enhanced control and visualization during procedures. This integration aims to make surgeries safer and more effective compared to traditional methods.
What is Vicarious Surgical's mission statement?
Vicarious Surgical's mission statement is centered around improving surgical outcomes through innovative robotic solutions. The company dedicates itself to advancing surgical technology in ways that enhance the experience for both patients and healthcare providers.
What is Vicarious Surgical's vision for the future of surgery?
Vicarious Surgical envisions a future where robotic-assisted surgeries become the standard for safety and precision in medical procedures. They aim to expand the capabilities of their technology and make advanced surgical techniques accessible to hospitals and surgeons worldwide.
What regulatory bodies does Vicarious Surgical need to comply with?
Vicarious Surgical must comply with regulatory bodies such as the U.S. Food and Drug Administration (FDA) for medical devices and surgical systems, as well as adhering to international standards for medical safety and efficacy that apply to their products in different markets.
What types of surgical procedures does Vicarious Surgical target?
Vicarious Surgical targets a wide range of surgical procedures across multiple specialties including general surgery, gynecology, urology, and more. Their technology is designed to assist in procedures where precision and minimally invasive techniques are critical for patient safety and recovery.
When was Vicarious Surgical Inc. founded?
Vicarious Surgical Inc. was founded in 2014 by Dr. Adam Sachs and others who recognized the potential for robotics to revolutionize surgery. The company's mission has been to develop more efficient and patient-friendly surgical technologies.
Where is Vicarious Surgical Inc. headquartered?
Vicarious Surgical Inc. is headquartered in Waltham, Massachusetts. This location provides the company access to a vibrant ecosystem of innovation and talent within the medical technology and robotics industries.
Who are the competitors of Vicarious Surgical?
Vicarious Surgical operates in a competitive landscape alongside other robotic surgical companies like Intuitive Surgical, Medtronic, and Johnson & Johnson. Each of these companies offers distinct technologies and approaches to robotic-assisted surgeries, making innovation and differentiation crucial.
Who are the key members of Vicarious Surgical's leadership team?
Vicarious Surgical's leadership team includes CEO Dr. Adam Sachs, who has extensive experience in robotics and engineering, and other professionals with backgrounds in healthcare, technology, and business. Their diverse expertise helps steer the company's innovative strategies.
What is the current price of Vicarious Surgical Inc. Class A Common Stock?
The current price of Vicarious Surgical Inc. Class A Common Stock is 1.880
When was Vicarious Surgical Inc. Class A Common Stock last traded?
The last trade of Vicarious Surgical Inc. Class A Common Stock was at 7:00 pm EST on December 29th, 2025
What is the market capitalization of Vicarious Surgical Inc. Class A Common Stock?
The market capitalization of Vicarious Surgical Inc. Class A Common Stock is 11.03M
How many shares of Vicarious Surgical Inc. Class A Common Stock are outstanding?
Vicarious Surgical Inc. Class A Common Stock has 5.87M shares outstanding.